Summary

Your ACE result shapes two things at once: whether your body is wired more for endurance or power, and how aggressively your renin-angiotensin system drives blood pressure — with the high-activity DD genotype favouring strength and sprint performance but carrying higher hypertension risk, and the low-activity II genotype favouring endurance and lower baseline blood pressure.

Genotype spectrum

AA (low ACE activity)

Endurance is where you shine. Your lower ACE activity means better oxygen efficiency, superior fatigue resistance during prolonged effort, and a cardiovascular system that runs cooler under sustained load.

AG (intermediate)

You have genuine metabolic flexibility — your physiology doesn't strongly bias toward either endurance or power, which means you can adapt well to both. This is actually an advantage for mixed-modality training and general fitness.

GG (high ACE activity)

Power and strength training is where your physiology excels. Higher ACE activity supports fast-twitch muscle recruitment, anaerobic capacity, and explosive performance.

II / TT (insertion homozygous)

Endurance performance and altitude tolerance. II carriers are significantly overrepresented among elite endurance athletes and high-altitude populations.

ID / GT (heterozygous)

Metabolic versatility. You respond reasonably well to both endurance and power training.

DD / GG (deletion homozygous)

Explosive power and sprint performance. DD carriers are overrepresented among elite sprinters and strength athletes.

Practical takeaway

For DD/GG Carriers (High ACE Activity)

Training design:
• Strength and power training is your natural domain. Your physiology supports explosive movements, heavy lifts, and sprint-based conditioning. Lean into this.
• Don't skip aerobic training. This is particularly important for you as cardiovascular counterbalance. 150+ minutes of moderate aerobic activity per week — not just for general health, but specifically because your RAS pushes vascular tone higher. Endurance training lowers resting angiotensin II and improves vascular compliance.
• Recovery between high-intensity sessions: Your sympathetic drive runs higher. Allow adequate recovery (48-72 hours between maximal effort sessions for the same muscle groups).

Blood pressure management:
• Monitor BP at least annually. Home monitoring is even better — establish your baseline and track trends.
• Potassium-rich diet: Bananas, sweet potatoes, spinach, avocado, white beans. Potassium directly counteracts angiotensin II's sodium-retaining effects. Target: 3,500-4,700 mg/day from food sources.
• Sodium moderation: Not extreme restriction, but awareness. Keep below 2,300 mg/day. If BP is already trending high, aim for 1,500 mg/day.
• Magnesium: Supports vascular relaxation. 400-420 mg/day (men), 310-320 mg/day (women). Magnesium glycinate or citrate.
• If BP medication is ever prescribed: Tell your GP about your ACE genotype. ACE inhibitors (enalapril, lisinopril, ramipril) are specifically effective for your genotype because you have more of the enzyme they target.

What "working" looks like:
• BP consistently below 130/80 mmHg
• Strength gains responding to progressive overload programming
• Adequate recovery markers (resting HR, HRV trending favourably)

Expected response window: BP response to dietary potassium and sodium modification: 2-4 weeks. Training adaptation to strength programming: 4-8 weeks for measurable gains.
For II/AA Carriers (Low ACE Activity)

Training design:
• Endurance training is where your physiology excels. Running, cycling, swimming, rowing — sustained aerobic work matches your genetic profile.
• Altitude training or events: You have a genuine advantage at elevation. If you're an endu

Evidence detail

What This Gene Does

ACE produces angiotensin-converting enzyme, which converts angiotensin I into angiotensin II — one of the most potent vasoconstrictors in the body. More ACE activity means more angiotensin II, which means higher vascular tone, more aldosterone secretion (sodium and water retention), and a cardiovascular system biased toward power output. Less ACE activity means a more relaxed vascular system, better oxygen efficiency, and a physiology that favours sustained effort.

This is a genuine dual-role gene. It matters for exercise physiology (what type of training your body responds to best) AND for cardiovascular risk (how hard your system pushes blood pressure upward). Both dimensions are clinically meaningful.

Mechanism

The renin-angiotensin system (RAS) works like this:

1. Renin (from kidneys) cleaves angiotensinogen (from liver) into angiotensin I — a relatively inactive peptide.
2. ACE converts angiotensin I into angiotensin II — a potent vasoconstrictor that also stimulates aldosterone release (sodium retention, potassium excretion) and sympathetic nervous system activation.
3. The I/D polymorphism determines how much ACE enzyme you produce. DD carriers produce roughly twice the circulating ACE as II carriers. More ACE → more angiotensin II → tighter vascular tone.

Why this affects exercise type:

Higher ACE/angiotensin II favours power through several mechanisms: increased sympathetic drive → better fast-twitch motor unit recruitment, angiotensin II acts as a growth factor for cardiac and skeletal muscle hypertrophy, and higher vascular tone supports short-burst blood pressure spikes during maximal lifts.

Lower ACE/angiotensin II favours endurance through: reduced peripheral resistance → better sustained oxygen delivery, improved metabolic efficiency during prolonged exercise, better bradykinin preservation (ACE also degrades bradykinin, a vasodilator — lower ACE means more bradykinin → more nitric oxide → better capillary blood flow), and superior altitude adaptation (less aldosterone → better fluid balance at altitude).

Why this affects blood pressure:

This is the same mechanism, viewed from a health rather than performance angle. Chronically elevated angiotensin II drives sustained vasoconstriction, sodium retention, vascular remodelling, and sympathetic activation. Over decades, this contributes to essential hypertension. The effect is modest from ACE alone (2-3 mmHg) but compounds with other RAS variants (AGT, AGTR1) to produce a clinically meaningful picture.

ACE Angiotensin

Summary

Genotype spectrum

Practical takeaway

Evidence detail

Sources (8)